FFCP PHASE2:Hg19::chrX:113302230..113302241,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chrX:113302230..113302241, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chrX:113302230..113302241, - |
| Coexpression cluster: | C132_acute_small_Dendritic_Macrophage_CD14_Neutrophils_Monocytederived |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chrX:113302230..113302241- |
|---|
0
1
2
3
4
5
6
7
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| myeloid cell | 6.23e-13 | 108 |
| common myeloid progenitor | 6.23e-13 | 108 |
| hematopoietic oligopotent progenitor cell | 9.40e-09 | 161 |
| hematopoietic multipotent progenitor cell | 9.40e-09 | 161 |
| hematopoietic stem cell | 2.15e-08 | 168 |
| hematopoietic cell | 5.65e-08 | 177 |
Showing 1 to 6 of 6 entries
| Ontology term | p-value | n |
|---|---|---|
| myeloid leukemia | 1.29e-44 | 31 |
| leukemia | 1.45e-35 | 39 |
| hematologic cancer | 2.68e-27 | 51 |
| immune system cancer | 2.68e-27 | 51 |
| organ system cancer | 2.97e-10 | 137 |
Showing 1 to 5 of 5 entries
